SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001400482-16-000259
Filing Date
2016-11-04
Accepted
2016-11-04 13:15:08
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2016q310-q.htm 10-Q 783853
2 EXHIBIT 10.1 exhibit101-rogergirardsepa.htm EX-10.1 70335
3 EXHIBIT 31.1 acucela-20160930xexhibit311.htm EX-31.1 11457
4 EXHIBIT 31.2 acucela-20160930xexhibit312.htm EX-31.2 11412
5 EXHIBIT 32.1 acucela-20160930xexhibit321.htm EX-32.1 6297
6 EXHIBIT 32.2 acucela-20160930xexhibit322.htm EX-32.2 6133
  Complete submission text file 0001400482-16-000259.txt   2915066

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acuc-20160930.xml EX-101.INS 441305
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acuc-20160930.xsd EX-101.SCH 23286
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acuc-20160930_cal.xml EX-101.CAL 43391
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acuc-20160930_def.xml EX-101.DEF 68860
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acuc-20160930_lab.xml EX-101.LAB 290899
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acuc-20160930_pre.xml EX-101.PRE 151909
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55133 | Film No.: 161974495
SIC: 2834 Pharmaceutical Preparations